D. Vignali

V. Kuchroo, S. Xiao, C. Brooks, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Human tolerogenic dendritic cells produce IL‐35 in the absence of other IL‐12 family members

D. Vignali, C. Kooten, Karen O. Dixon, 2015, European journal of immunology.

Retroviral-Mediated Stem Cell Gene Nonobese Diabetic Mice: Generation by Decarboxylase 65-Specific TCR Retrogenic Diabetes Incidence Is Unaltered in Glutamate

D. Vignali, P. Arnold, A. Burton, 2004 .

Diabetes Incidence Is Unaltered in Glutamate Decarboxylase 65-Specific TCR Retrogenic Nonobese Diabetic Mice: Generation by Retroviral-Mediated Stem Cell Gene Transfer1

D. Vignali, P. Arnold, A. Burton, 2004, The Journal of Immunology.

Verification of 2A peptide cleavage.

D. Vignali, K. M. Vignali, A. Szymczak-Workman, 2012, Cold Spring Harbor protocols.

Treg‐recruiting microspheres prevent inflammation in a murine model of dry eye disease

J. Schuman, M. Fedorchak, Abhinav P Acharya, 2017, Journal of controlled release : official journal of the Controlled Release Society.

Regulatory T Cells: Their Role, Mechanism of Action, and Impact on Cancer

D. Vignali, A. Cillo, 2018 .

The composition and signaling of the IL-35 receptor are unconventional

K. Garcia, C. Drake, C. Hunter, 2012, Nature Immunology.

Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules

J. Strominger, R. Urban, D. Vignali, 1993, European journal of immunology.

Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?

D. Vignali, Anabelle Visperas, 2016, The Journal of Immunology.

Immunoregulation of Th cells by naturally processed peptide antagonists.

D. Vignali, K. M. Vignali, R. T. Carson, 1999, Journal of immunology.

Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size

William S. Lane, William Arbuthnot Sir Lane, J. Strominger, 1992, Nature.

Death Pathways Mediate Suppression via Programmed Cell Cutting Edge: Regulatory T Cells Do Not

Greg M. Delgoffe, D. Vignali, Andrea L. Szymczak-Workman, 2011 .

Inhibitory role of the transcription repressor Gfi1 in the generation of thymus-derived regulatory T cells

H. Chi, G. Neale, N. Kalupahana, 2013, Proceedings of the National Academy of Sciences.

Addendum: Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vector

Andrea L. Szymczak, D. Vignali, E. Vanin, 2004, Nature Biotechnology.

A Hybrid Insulin Epitope Maintains High 2D Affinity for Diabetogenic T Cells in the Periphery

B. Evavold, D. Vignali, Baoyu Liu, 2019, Diabetes.

Cutting Edge: Virus-Specific CD4+ Memory T Cells in Nonlymphoid Tissues Express a Highly Activated Phenotype1

L. Cauley, D. Woodland, D. Vignali, 2002, The Journal of Immunology.

Targeting Tregs in Tumors.

D. Vignali, 2022, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Thymus-specific serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in mice.

A. Carrier, B. Malissen, C. Viret, 2011, The Journal of clinical investigation.

Treg Fragility: A Prerequisite for Effective Antitumor Immunity?

D. Vignali, Abigail E. Overacre-Delgoffe, A. Overacre-Delgoffe, 2018, Cancer Immunology Research.

T(reg) stability: to be or not to be.

D. Vignali, Abigail E. Overacre, 2016, Current opinion in immunology.

Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells.

D. Vignali, D. Serreze, T. DiLorenzo, 2008, Journal of immunological methods.

Cutting Edge: Regulatory T Cells Do Not Require Stimulation through Their TCR to Suppress1

D. Vignali, C. Workman, Andrea L. Szymczak-Workman, 2009, The Journal of Immunology.

Does CD4 help to maintain the fidelity of T cell receptor specificity?

D. Vignali, J. Moreno, G. Hämmerling, 1992, International immunology.

Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules

D. Vignali, J. Moreno, G. Hämmerling, 1992, The Journal of experimental medicine.

Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.

L. Adorini, G. Hämmerling, D. Vignali, 1991, Journal of immunology.

Spedes-specific Binding of CD 4 to the / 32 Domain of Major Histocompatibility Complex Class II Molecules

D. Vignali, D. Schiller, 2003 .

The dichotomy of peptide presentation by class I and class II MHC proteins.

J. Strominger, R. Urban, D. Vignali, 1993, Chemical immunology.

Tonic ubiquitylation controls T‐cell receptor:CD3 complex expression during T‐cell development

M. Mingueneau, B. Malissen, H. Band, 2010, The EMBO journal.

Negative and positive selection by HLA-DR3(DRw17) molecules in transgenic mice

G. Schönrich, G. Hämmerling, D. Vignali, 2004, Immunogenetics.

Corrigendum: Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vector

Andrea L. Szymczak, D. Vignali, E. Vanin, 2004, Nature Biotechnology.

Reliable generation and use of MHC class II:gamma2aFc multimers for the identification of antigen-specific CD4(+) T cells.

N. L. La Gruta, L. Cauley, S. Swain, 2002, Journal of immunological methods.

Highly Activated Phenotype T Cells in Nonlymphoid Tissues Express a Memory + Cutting Edge : Virus-Specific CD 4

L. Cauley, D. Woodland, D. Vignali, 2002 .

Localized Multi‐Component Delivery Platform Generates Local and Systemic Anti‐Tumor Immunity

Yadong Wang, Abhinav P Acharya, S. Little, 2017 .

Regulatory T Cell–Derived TRAIL Is Not Required for Peripheral Tolerance

D. Vignali, C. Workman, Qianxia Zhang, 2021, ImmunoHorizons.

Peripheral Tolerance Derived TRAIL Is Not Required for − Regulatory T Cell

D. Vignali, Qianxia Zhang, Stephanie Grebinoski, 2021 .

Globule Leukocytes and Other Mast Cells in the Mouse Intestine

Asha B. Pillai, Deepali V. Sawant, J. Rehg, 2018, Veterinary pathology.

COVID-19 versus Non–COVID-19 Acute Respiratory Distress Syndrome: Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers, and Clinical Outcomes

Janet S. Lee, B. Methé, A. Ray, 2021, Annals of the American Thoracic Society.

CD40-Induced Aggregation of MHC Class II and CD80 on the Cell Surface Leads to an Early Enhancement in Antigen Presentation 1

D. Vignali, J. Moreno, L. Bonifaz, 2003, The Journal of Immunology.

Early Enhancement in Antigen Presentation and CD 80 on the Cell Surface Leads to an CD 40-Induced Aggregation of MHC Class II

D. Vignali, J. Moreno, L. Bonifaz, 2003 .

Treg-specific IL-27Rα deletion uncovers a key role for IL-27 in Treg function to control autoimmunity

W. Baldwin, A. Ting, N. Dvorina, 2017, Proceedings of the National Academy of Sciences.

Differential CD3 zeta phosphorylation is not required for the induction of T cell antagonism by altered peptide ligands.

D. Vignali, H. Liu, 1999, Journal of immunology.

Interleukin-33 activates regulatory T cells to suppress innate γδ T cell responses in the lung

Josalyn L Cho, B. Medoff, A. Luster, 2020, Nature Immunology.

Inhibitory receptor agonists: the future of autoimmune disease therapeutics?

D. Vignali, Stephanie Grebinoski, 2020, Current opinion in immunology.

Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study

Michele D. Sobolewski, Janet S. Lee, J. Mellors, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Majority of Immunogenic Epitopes Generate CD4+ T Cells That Are Dependent on MHC Class II-Bound Peptide-Flanking Residues

N. L. La Gruta, D. Woodland, D. Vignali, 2002, The Journal of Immunology.

Mobilizing phospholipids on tumor plasma membrane implicates phosphatidylserine externalization blockade for cancer immunotherapy

Jacob Stewart-Ornstein, G. Quarato, B. Lu, 2022, Cell reports.

Immunity to Schistosoma mansoni in vivo: contradiction or clarification?

D. Vignali, M. Taylor, Q. Bickle, 1989, Immunology today.

Studies on immunity to Schistosoma mansoni in vivo: whole-body irradiation has no effect on vaccine-induced resistance in mice

D. Vignali, M. Taylor, Q. Bickle, 1988, Parasitology.

Unexpected role for MHC II–peptide complexes in shaping CD8 T-cell expansion and differentiation in vivo

A. Valujskikh, R. Fairchild, D. Vignali, 2012, Proceedings of the National Academy of Sciences.

The CD3ε Proline-Rich Sequence, and Its Interaction with Nck, Is Not Required for T Cell Development and Function1

E. Palmer, Andrea L. Szymczak, D. Vignali, 2005, The Journal of Immunology.

The Proline-Rich Sequence of CD3ε as an Amplifier of Low-Avidity TCR Signaling1

S. Robbins, D. Vignali, P. Santamaria, 2008, The Journal of Immunology.

Epitope Mapping of Therapeutic Antibodies Targeting Human LAG3

R. Mariuzza, D. Vignali, C. Workman, 2022, The Journal of Immunology.

Architectural Changes in the TCR:CD3 Complex Induced by MHC:Peptide Ligation1

N. L. La Gruta, D. Wiest, D. Vignali, 2004, The Journal of Immunology.

De novo identification of CD4+ T cell epitopes

Mark S. Anderson, D. Vignali, Sanya Arshad, 2022, bioRxiv.

Induction of immunity against Schistosoma mansoni by drug (Roll‐3128)‐terminated infections: analysis of surface antigen recognition

D. Vignali, M. Sacko, Q. Bickle, 1990, Parasite immunology.

Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15.

H. Heslop, C. Rooney, W. Xie, 2003, Cytotherapy.

T-Cell Antigen Receptor

Andrea L. Szymczak, D. Vignali, 2004 .

An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell suppressive function and therapeutic efficacy

W. Baldwin, R. Fairchild, N. Dvorina, 2015, Mucosal Immunology.

A Bayesian mixture model for clustering droplet-based single-cell transcriptomic data from population studies

Li Chen, Wei Chen, Ying Ding, 2019, Nature Communications.

A role for CD4+ but not CD8+ T cells in immunity to Schistosoma mansoni induced by 20 krad-irradiated and Ro 11-3128-terminated infections.

H. Waldmann, S. Cobbold, P. Crocker, 1989, Immunology.

Histological examination of the cellular reactions around schistosomula of Schistosoma mansoni in the lungs of sublethally irradiated and unirradiated, immune and control rats

D. Vignali, M. Taylor, Q. Bickle, 1989, Parasitology.

Comparison of the role of complement in immunity to Schistosoma mansoni in rats and mice.

M. Pepys, G. Tennent, D. Vignali, 1988, Immunology.

Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells.

C. Rooney, W. Xie, P. Piedra, 2004, Blood.

Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition

H. Osmanbeyoglu, R. Buckanovich, D. Vignali, 2021, Science advances.

Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8+ T Cell-Derived Interferon-γ.

D. Stolz, R. Deshpande, Greg M. Delgoffe, 2019, Immunity.

Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8 T Cells1

D. Getnet, C. Drake, D. Pardoll, 2009, The Journal of Immunology.

Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing

Patricia M. Santos, R. Ferris, Seungwon Kim, 2021, Nature Communications.

A Bayesian mixture model for clustering droplet-based single-cell transcriptomic data from population studies

Hongyi Xin, Ying Ding, J. Kolls, 2019, Nature Communications.

Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer.

Steffi Oesterreich, Ting Wang, Umamaheswar Duvvuri, 2019, Immunity.

Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism

Adrian V. Lee, G. Tseng, S. Oesterreich, 2018, Scientific Reports.

PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance

Loise M. Francisco, G. Freeman, C. Lian, 2020, The Journal of experimental medicine.

A Bayesian mixture model for clustering droplet-based single-cell transcriptomic data from population studies

Zhe Sun, Wei Chen, Ying Ding, 2018, Nature Communications.

Neuropilin-1 is a T cell memory checkpoint limiting long-term anti-tumor immunity

E. Lipson, R. Ferris, D. Normolle, 2020, Nature Immunology.

Inhibitory signaling sustains a distinct early memory CD8+ T cell precursor that is resistant to DNA damage

Jesse M. Platt, E. Wherry, A. Sharpe, 2021, Science Immunology.

The Majority of Immunogenic Epitopes Generate CD4+ T Cells That Are Dependent on MHC Class II-Bound Peptide-Flanking Residues1

David L. Woodland, N. L. La Gruta, D. Woodland, 2002, The Journal of Immunology.

Cooperative Recognition of MHC Class II:Peptide Complexes by the T Cell Receptor and CD4

D. Vignali, 1996 .

Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors

George C. Tseng, Steffi Oesterreich, Adrian V. Lee, 2019, Journal of Immunotherapy for Cancer.

Metabolic support of tumor-infiltrating regulatory T cells by lactic acid

J. Rothstein, Greg M. Delgoffe, B. Morrison, 2020, Nature.

Phase I trial of cetuximab, radiation therapy, and ipilimumab in locally advanced head and neck cancer.

D. Heron, R. Ferris, Seungwon Kim, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Generation of T-cell receptor retrogenic mice

Jeff Holst, J. Holst, D. Vignali, 2006, Nature Protocols.

Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer.

D. Vignali, T. Hand, A. Cillo, 2021, Immunity.

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

R. Soose, R. Ferris, Seungwon Kim, 2021, Nature Communications.

Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups

D. Vignali, H. Yano, Lawrence P. Andrews, 2019, Nature Immunology.

Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer

J. Luketich, J. Kirkwood, R. Ferris, 2021, Science Translational Medicine.

Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy

D. Vignali, C. Workman, T. Bruno, 2020, Journal for ImmunoTherapy of Cancer.

Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding

D. Irvine, J. Kirkwood, E. Lipson, 2017, Science Immunology.

Microbiome-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer

D. Vignali, T. Hand, A. Cillo, 2021, bioRxiv.

ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation

Adrian V. Lee, G. Tseng, O. Cohen, 2020, Nature Communications.

Distinct T cell receptor signaling pathways drive proliferation and cytokine production in T cells

Iannis Aifantis, Mark M. Davis, Johannes B. Huppa, 2013, Nature Immunology.

The proline-rich sequence of CD3epsilon as an amplifier of low-avidity TCR signaling.

S. Robbins, D. Vignali, P. Santamaria, 2008, Journal of immunology.

Lentiviral Vectors Encoding Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Receptor Genes Efficiently Convert Peripheral Blood CD8 T Lymphocytes into Cytotoxic T Lymphocytes with Potent In Vitro and In Vivo HIV-1-Specific Inhibitory Activity

B. Walker, C. Brander, K. Sango, 2008, Journal of Virology.

Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptor.

D. Vignali, C. Workman, T. Bruno, 2019, Seminars in immunology.

Design and construction of 2A peptide-linked multicistronic vectors.

D. Vignali, Andrea L. Szymczak-Workman, Andrea L Szymczak-Workman, 2012, Cold Spring Harbor protocols.

Interleukin-35: Expanding Its Job Profile.

Deepali V. Sawant, D. Vignali, K. Hamilton, 2015, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

A Cre-driven allele-conditioning line to interrogate CD4+ conventional T cells.

E. Wherry, A. Sharpe, I. Taniuchi, 2021, Immunity.

Janet S. Lee, J. Mellors, P. Bjorkman, 2021, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Competition for Active TGFβ Cytokine Allows for Selective Retention of Antigen-Specific Tissue- Resident Memory T Cells in the Epidermal Niche.

D. Griggs, Harinder Singh, T. Hirai, 2020, Immunity.

On the dynamics of TCR:CD3 complex cell surface expression and downmodulation.

D. Wiest, D. Vignali, H. Liu, 2000, Immunity.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Combination immunotherapy: Where do we go from here?

M. Sznol, D. Pardoll, S. Kurtulus, 2015, Journal of Immunotherapy for Cancer.

Opening the Door for Immune Oncology Studies in Invasive Lobular Breast Cancer.

S. Oesterreich, P. Mcauliffe, D. Vignali, 2018, Journal of the National Cancer Institute.

B cell–Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer

G. Gupta, B. Vincent, N. Rashid, 2020, Cancer Immunology Research.

Systemic immune dysfunction in cancer patients driven by IL6 and IL8 induction of an inhibitory receptor module in peripheral CD8+ T cells

Simon C Watkins, J. Herman, J. Kirkwood, 2020, bioRxiv.

Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor

J. Strominger, D. Vignali, J L Strominger, 1994, The Journal of experimental medicine.

Stimulated CD8 T Cells Subsets on Activated and Chronically Functionally Distinct LAG-3 and PD-1

D. Getnet, D. Pardoll, D. Vignali, 2009 .

B7-H4 Modulates Regulatory CD4+ T Cell Induction and Function via Ligation of a Semaphorin 3a/Plexin A4/Neuropilin-1 Complex

Lieping Chen, H. Chi, S. Langermann, 2018, The Journal of Immunology.

PROCESSING OF AN ENDOGENOUS PROTEIN CAN GENERATE MHC CLASS THOSE DERIVED FROM EXOGENOUS ANTIGEN 11-RESTRICTED T CELL DETERMINANTS DISTINCT FROM

L. Adorini, G. Hämmerling, D. Vignali, 1991 .

Rapid analysis of T-cell selection in vivo using T cell–receptor retrogenic mice

J. Holst, D. Vignali, A. Burton, 2006 .

Binding of the cytoplasmic domain of CD28 to the plasma membrane inhibits Lck recruitment and signaling

J. Godec, A. Sharpe, K. Wucherpfennig, 2016, Science Signaling.

Generation of 2A-linked multicistronic cassettes by recombinant PCR.

D. Vignali, Andrea L. Szymczak-Workman, A. Szymczak-Workman, 2012, Cold Spring Harbor protocols.

Bifurcated monocyte states are predictive of mortality in severe COVID-19

Janet S. Lee, Jishnu Das, P. Benos, 2021, bioRxiv.

Catch and release: freeing up PD-L1 ameliorates autoimmunity

D. Vignali, Stephanie Grebinoski, Angela M. Gocher-Demske, 2022, Nature Immunology.

Reduce Proportion and Activity of NK Cells in the Lung of Idiopathic Pulmonary Fibrosis Patients.

M. Rojas, R. Lafyatis, D. Vignali, 2021, American Journal of Respiratory and Critical Care Medicine.

Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment

Adrian V. Lee, Mostofa Rafid Uddin, K. Pogue-Geile, 2023, Nature Cancer.

The CD3epsilon proline-rich sequence, and its interaction with Nck, is not required for T cell development and function.

E. Palmer, Andrea L. Szymczak, D. Vignali, 2005, Journal of immunology.

Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment

Stacy L. Gelhaus, D. Davar, J. McCulloch, 2023, Cell.

Pathological Tau transmission initiated by binding lymphocyte-activation gene 3

David W. Nauen, P. Wong, J. Troncoso, 2023, bioRxiv.

Identification of the Docking Site for CD3 on the T Cell Receptor β Chain by Solution NMR*

Ming Luo, John Orban, Yihong Chen, 2015, The Journal of Biological Chemistry.

Liver-specific T regulatory type-1 cells program local neutrophils to suppress hepatic autoimmunity via CRAMP.

P. Kubes, Saswat Mohapatra, D. Vignali, 2021, Cell reports.

Molecular Pathways and Mechanisms of LAG-3 in Cancer Therapy.

J. Kirkwood, D. Vignali, C. Workman, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease

T. Nomura, T. Mimori, S. Matsuda, 2014, Science.

A Natural Structural Variant of the Mouse TCR β-Chain Displays Intrinsic Receptor Function and Antigen Specificity1

M. Ciofani, O. Michielin, D. Vignali, 2006, The Journal of Immunology.

Interactions of CD4 with MHC class II molecules, T cell receptors and p56lck.

J. Strominger, M. Kinch, D. Vignali, 1993, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell suppressive function and therapeutic efficacy

W. Baldwin, R. Fairchild, N. Dvorina, 2015, Mucosal Immunology.

Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism

Adrian V. Lee, G. Tseng, S. Oesterreich, 2018, Scientific Reports.

Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19

Janet S. Lee, Jishnu Das, B. Methé, 2022, bioRxiv.

The GPCR–Gαs–PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure

Alexander T. Wenzel, J. Mesirov, E. Ruppin, 2023, Nature Immunology.

Ewing sarcoma and osteosarcoma have distinct immune signatures and intercellular communication networks.

M. Burgess, S. Ranganathan, Kelly M. Bailey, 2022, Clinical Cancer Research.

The Great Immune Escape: Understanding the Divergent Immune Response in Breast Cancer Subtypes.

Adrian V. Lee, S. Oesterreich, D. Vignali, 2022, Cancer discovery.

Distinct T cell receptor signaling pathways drive proliferation and cytokine production in T cells

Mark M. Davis, P. Dempsey, H. Crawford, 2013, Nature Immunology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.